APA

de Jong H. M. Y., van Mens L. J. J., Nurmohamed M. T., Kok M. R., van Kuijk A. W. R., Baeten D. L. P. & van de Sande M. G. H. (20200826). Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial. : Arthritis research & therapy.

Chicago

de Jong Henriëtte M Y, van Mens Leonieke J J, Nurmohamed Michael T, Kok Marc R, van Kuijk Arno W R, Baeten Dominique L P and van de Sande Marleen G H. 20200826. Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial. : Arthritis research & therapy.

Harvard

de Jong H. M. Y., van Mens L. J. J., Nurmohamed M. T., Kok M. R., van Kuijk A. W. R., Baeten D. L. P. and van de Sande M. G. H. (20200826). Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial. : Arthritis research & therapy.

MLA

de Jong Henriëtte M Y, van Mens Leonieke J J, Nurmohamed Michael T, Kok Marc R, van Kuijk Arno W R, Baeten Dominique L P and van de Sande Marleen G H. Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial. : Arthritis research & therapy. 20200826.